382 publications

Name Date Type Actions

Serving animal Health - 90 years

Serving animal Health for over 90 years

 		06/03/2023 Press releases communication

In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years

The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health.

 		31/01/2023 Press releases communication

Annual sales 2022

Total group Sales: €540 million (up 3.6% as reported)
Annual Sales of Essential products: €304 million (up 4.5% as reported)

 		18/01/2023 Public releases

First nine months 2022 sales: €405M

In line with year-end outlook

 		12/10/2022 Public releases

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

 		23/09/2022 Public releases , Half Year Report

2022 HALF YEAR RESULTS

Sales: €271m (up 6.0% as reported)
Essentials sales: €154m (up 9.8% as reported)
EBIT before depreciation of acquired assets: €52m (19.0% of sales)
Net income - Group share: €21m (7.9% of sales)
EBITDA: €62m (22.9% of sales)

 		15/09/2022 Public releases

H1 2022 Sales

H1 2022 Sales: €271m, up 6.1%
+2.0% on a like-for-like basis
H1 2022 Essentials Sales: €154m, up 9.8%
+6.8% on a like-for-like basis

 		20/07/2022 Public releases

Buyback programs - may 2022

Monthly communication regarding buyback programs

 		03/06/2022 Monthly communication regarding buyback programs

Buyback programs - april 2022

Monthly communication regarding buyback programs

 		05/05/2022 Monthly communication regarding buyback programs

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

 		22/04/2022 Public releases